Impact of in utero opioid exposure on newborn outcomes: beyond neonatal opioid withdrawal syndrome

References

• Kozhimannil KB, Graves AJ, Levy R, et al. Nonmedical use of prescription opioids among pregnant U.S. women. Women Health Issue. 2017;27(3):308–315.
   PubMed Web of Science ®Google Scholar
• Malek A, Mattison DR. Drugs and medicines in pregnancy: the placental disposition of opioids. CPB. 2011;12(5):797–803.
   Google Scholar
• Lemon LS, Caritis SN, Venkataramanan R, et al. Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome. Epidemiology. 2018; 9:261–268.
   Google Scholar
• Hudak ML, Tan RC, Frattarelli DAC, The Committee on Drugs, The committee on Fetus and Newborn, et al. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–560.
   PubMed Web of Science ®Google Scholar
• Winkelman TNA, Villapiano N, Kozhimannil KB, et al. Incidence and costs of neonatal abstinence syndrome among infants with medicaid: 2004-2014. Pediatrics. 2018;141(4):e20173520.
   PubMed Web of Science ®Google Scholar
• Strahan AE, Guy GP, Jr, Bohm M, et al. Neonatal abstinence syndrome incidence and health care costs in the United States, 2016. JAMA Pediatr. 2019;174(2):200–202.
   Web of Science ®Google Scholar
• Brown JD, Goodin AJ, Talbert JC. Rural and appalachian disparities in neonatal abstinence syndrome incidence and access to opioid abuse treatment. J Rural Health. 2018;34(1):6–13.
   PubMed Web of Science ®Google Scholar
• Rossen LM, Bastian B, Warner M, et al. Drug poisoning mortality: United States, 2003–2017. National Center for Health Statistics. 2019. https://www.cdc.gov/nchs/data-visualization/drug-poisoning-mortality/
   Google Scholar
• Conner KL, Meadows AL, Delcher C, et al. Neonatal abstinence syndrome and childhood mental health conditions, 2009–2015: commercial versus Medicaid populations. PS. 2020;71(2):184–187.
   Google Scholar
• Ramphul K, Mejias SG, Joynauth J. An update on the burden of neonatal abstinence syndrome in the United States. Hosp Pediatr. 2020;10(2):181–184.
   PubMedGoogle Scholar
• Brogly SB, Saia KA, Walley AY, et al. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and Meta-analysis. Am J Epidemiol. 2014;180(7):673–686.
   PubMed Web of Science ®Google Scholar
• Yazdy MM, Desai RJ, Brogly SB. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 2015;04(02):056–070.
   Google Scholar
• Smith MV, Costello D, Yonkers KA. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J. 2015;19(3):548–556.
   PubMed Web of Science ®Google Scholar
• Sujan AC, Quinn PD, Rickert ME, et al. Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study. PLOS Med. 2019;16(12):e1002980.
   PubMed Web of Science ®Google Scholar
• Brogly SB, Velez MP, Werler MM, et al. Prenatal opioid analgesics and the risk of adverse birth outcomes. Epidemiology. 2021;32(3):448–456.
   PubMed Web of Science ®Google Scholar
• Fishman B, Daniel S, Koren G, et al. Pregnancy outcome following opioid exposure: a cohort study. PLOS One. 2019;14(7):e0219061.
   PubMed Web of Science ®Google Scholar
• Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842–850.
   PubMed Web of Science ®Google Scholar
• Jawdeh EGA, Westgate PM, Pant A, et al. Prenatal opioid exposure and intermittent hypoxemia in preterm infants: a retrospective assessment. Front Pediatr. 2017;5:253.
   PubMed Web of Science ®Google Scholar
• Flannagan KS, Sjaarda LA, Mumford SL, et al. Prescription opioid use among populations of reproductive age: effects on fertility, pregnancy loss, and pregnancy complications. Epidemiol Rev. 2020;42(1):117–133.
   PubMed Web of Science ®Google Scholar
• Jarlenski MP, Paul NC, Krans EE. Polysubstance use among pregnant women with opioid use disorder in the United States, 2007-2016. Obstet Gynecol. 2020;136(3):556–564.
   PubMed Web of Science ®Google Scholar
• Conradt E, Flannery T, Aschner JL, et al. Prenatal opioid exposure: Neurodevelopmental consequences and future research priorities. Pediatrics. 2019;144(3)pii:e20190128.
   Web of Science ®Google Scholar
• Shearer JN, Erwin PC, Davis SK, et al. Implications of Tennessee's opioid legislation for neonatal abstinence syndrome. Policy Polit Nurs Pract. 2019;20(3):153–162.
   PubMedGoogle Scholar
• Hart BJ, Viswanathan S, Jadcherla SR. Prenatal opioid exposure, neonatal abstinence syndrome/neonatal opioid withdrawal syndrome, and later child development research: Shortcomings and solutions. J Matern Fetal Neonatal Med. 2019;32(21):3633–3639.
   PubMed Web of Science ®Google Scholar
• Stein Y, Hwang S, Liu CL, et al. The association of concomitant maternal marijuana use on health outcomes for opioid exposed newborns in Massachusetts, 2003–2009. J Pediatr. 2020;218:238–242.
   PubMed Web of Science ®Google Scholar
• Finnegan LP, Connaughton JF, Kron RE, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1–2):141–158.
   PubMedGoogle Scholar
• Kotelchuck M. An evaluation of the kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. Am J Public Health. 1994;84(9):1414–1420.
   PubMed Web of Science ®Google Scholar
• Jilani SM, Frey MT, Pepin D, et al. Evaluation of state-mandated reporting of neonatal abstinence syndrome — six states, 2013–2017. MMWR Morb Mortal Wkly Rep. 2019;68(1):6–10.
   PubMed Web of Science ®Google Scholar
• Rehan VK, Asotra K, Torday JS. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung. 2009;187(5):281–289.
   PubMed Web of Science ®Google Scholar
• Tree KC, Scotto di Perretolo M, Peyronnet J, et al. In utero cannabinoid exposure alters breathing and the response to hypoxia in newborn mice. Eur J Neurosci. 2014;40(1):2196–2204.
   PubMed Web of Science ®Google Scholar
• Knutson AO, Watters JJ. All roads lead to inflammation: is maternal immune activation a common culprit behind environmental factors impacting offspring neural control of breathing? Respir Physiol Neurobiol. 2020;274:103361.
   PubMed Web of Science ®Google Scholar
• van der Ham DP, van Kuijk S, Opmeer BC, et al. Can neonatal sepsis be predicted in late preterm premature rupture of membranes? Development of a prediction model. Eur J Obstet Gynecol Reprod Biol. 2014;176:90–95.
   PubMed Web of Science ®Google Scholar